Upexi, Inc. (NASDAQ:UPXI) Short Interest Update

Upexi, Inc. (NASDAQ:UPXI) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 61,000 shares, a growth of 119.4% from the March 31st total of 27,800 shares. Approximately 5.9% of the company’s stock are short sold. Based on an average daily trading volume, of 2,120,000 shares, the short-interest ratio is presently 0.0 days.

Upexi Trading Down 16.7 %

Upexi stock opened at $12.92 on Tuesday. The firm has a fifty day moving average price of $3.70 and a two-hundred day moving average price of $4.20. Upexi has a fifty-two week low of $1.90 and a fifty-two week high of $22.57. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.58 and a quick ratio of 0.53.

Upexi (NASDAQ:UPXI) last announced its earnings results on Friday, February 14th. The company reported ($1.24) earnings per share for the quarter. The company had revenue of $4.01 million during the quarter.

Insiders Place Their Bets

In other news, Director Gene Salkind purchased 241,229 shares of the company’s stock in a transaction dated Thursday, April 17th. The shares were bought at an average price of $2.28 per share, with a total value of $550,002.12. Following the completion of the transaction, the director now directly owns 365,127 shares in the company, valued at $832,489.56. This trade represents a 194.70 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Allan Marshall acquired 657,895 shares of the firm’s stock in a transaction that occurred on Thursday, April 17th. The shares were purchased at an average cost of $2.28 per share, with a total value of $1,500,000.60. Following the completion of the acquisition, the chief executive officer now owns 809,318 shares in the company, valued at $1,845,245.04. This trade represents a 434.47 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased 942,984 shares of company stock valued at $2,150,004 over the last quarter. Insiders own 34.65% of the company’s stock.

Institutional Investors Weigh In On Upexi

An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can purchased a new stake in Upexi, Inc. (NASDAQ:UPXI) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned 0.81% of Upexi at the end of the most recent reporting period. Institutional investors own 5.68% of the company’s stock.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.